CELG.RT

Bristol-Myers Squibb Company Contingent Value Rights

18 hedge funds and large institutions have $4.17M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Holders
18
Holders Change
-2
Holders Change %
-10%
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
Increased
3
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
FCM
1
FourWorld Capital Management
New York
$4.15M 100,000
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$5.01K 122,175 +44,117 +57%
TCA
3
Transcend Capital Advisors
New Jersey
$4.83K 117,775
DC
4
Davenport & Co
Virginia
$3.44K 83,970
Citadel Advisors
5
Citadel Advisors
Florida
$1.55K 37,904 -130 -0.3%
Fifth Third Bancorp
6
Fifth Third Bancorp
Ohio
$820 20,000
PAG
7
Private Advisor Group
New Jersey
$615 15,000
Bank of America
8
Bank of America
North Carolina
$75 1,838
Northwestern Mutual Wealth Management
9
Northwestern Mutual Wealth Management
Wisconsin
$14 341 +99 +41%
IAIM
10
International Assets Investment Management
Florida
$7 175
Morgan Stanley
11
Morgan Stanley
New York
$7 164
RIL
12
Rothschild Investment LLC
Illinois
$7 166
OC
13
Oakworth Capital
Alabama
$5 125
AEPWM
14
Atlantic Edge Private Wealth Management
Florida
$1 16
JPMorgan Chase & Co
15
JPMorgan Chase & Co
New York
$1 23
Wells Fargo
16
Wells Fargo
California
$1 28
UBS Group
17
UBS Group
Switzerland
$1 31 +1 +3%
CAPTRUST Financial Advisors
18
CAPTRUST Financial Advisors
North Carolina
-20,498 Closed
TPA
19
Trivium Point Advisory
Connecticut
-10,000 Closed
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
$0 2,475
CFGS
21
Concourse Financial Group Securities
Alabama